Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report.

Abstract

In this article, a case of decubitus ulcer infection caused by an extended-spectrum beta-lactamase-producing Proteus mirabilis strain, successfully treated with oral amoxicillin-clavulanate (1-month therapy) is described. This article focuses on diffusion and clinical effect of extended-spectrum beta-lactamases-producing Proteus mirabilis on treatment of gram negative lower extremity infections.

• Authors: Vincenzo Savini, Chiara Catavitello, Marzia Talia, Fabio Di Berardino, Assunta Manna, Andrea Balbinot, Fabio Febbo, Daniela Carlino, Francesca Fioritoni, Giovanni Di Bonaventura, Domenico D'Antonio
• Journal: The international journal of lower extremity wounds (Int J Low Extrem Wounds) Vol. 7 Issue 2 Pg. 99-101 (Jun 2008) ISSN: 1534-7346 [Print] United States
• PMID: 18483010 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Bacterial Agents
• beta-Lactams

Topics

• Aged
• Anti-Bacterial Agents (pharmacology, therapeutic use)
• Drug Resistance, Bacterial
• Drug Therapy, Combination
• Humans
• Male
• Microbial Sensitivity Tests
• Pressure Ulcer (microbiology)
• Proteus Infections (diagnosis, drug therapy, microbiology)
• Proteus mirabilis
• Wound Infection (diagnosis, drug therapy, microbiology)
• beta-Lactams (pharmacology, therapeutic use)